About Truveta
Truveta is a company based in Seattle (United States) founded in 2020. Truveta has raised $515 million across 4 funding rounds from investors including Microsoft, Illumina and Regeneron Pharmaceuticals. Truveta offers products and services including Truveta Data, Truveta Language Model, Truveta Studio, and Genomics Solutions. Truveta operates in a competitive market with competitors including Carta Healthcare, Flywheel, Verana Health, Clearsense and nference, among others.
- Headquarter Seattle, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$515 M (USD)
in 4 rounds
-
Latest Funding Round
$320 M (USD), Series C
Jan 13, 2025
-
Investors
Microsoft
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Truveta
Truveta offers a comprehensive portfolio of products and services, including Truveta Data, Truveta Language Model, Truveta Studio, and Genomics Solutions.
Provides EHR data for research and analytics purposes.
Analyzes clinical notes and images for health insights.
Facilitates collaboration on health data studies and trials.
Supports drug discovery through genotypic and phenotypic data.
People of Truveta
Unlock access to complete
Unlock access to complete
Software Development Team
52 people
Leadership Team
26 people
Sales and Marketing
10 people
Data Analysis and Operations Team
10 people
Product Management Team
9 people
Senior Team
4 people
Finance and Accounting
3 people
Legal and Compliance
2 people
Unlock access to complete
Funding Insights of Truveta
Truveta has successfully raised a total of $515M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $320 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Truveta
Truveta has secured backing from 9 investors, including institutional investors. Prominent investors backing the company include Microsoft, Illumina and Regeneron Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Antibodies are developed for treating cancer, eye, and inflammatory diseases.
|
Locked | Locked | Locked | |
|
Trinity Health is recognized for providing healthcare and community services.
|
Locked | Locked | Locked | |
|
A chain of multispecialty hospitals is operated in New York.
|
Locked | Locked | Locked |
Investor details for Truveta
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Truveta
Investment portfolio details for Truveta
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Truveta
Detailed financials for Truveta
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Truveta Comparisons
Peer comparison for Truveta
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Truveta
Truveta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Carta Healthcare, Flywheel, Verana Health, Clearsense and nference, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-driven clinical data management tools are offered to healthcare providers.
|
|
| Locked | Locked | Locked |
Cloud-based platform for healthcare data capture and analysis is offered.
|
|
| Locked | Locked | Locked |
Verana Health is focused on real-world data analytics in healthcare.
|
|
| Locked | Locked | Locked |
Healthcare analytics platforms and applications are developed for clinicians.
|
|
| Locked | Locked | Locked |
AI platform provided for clinical data analysis and insights.
|
|
| Locked | Locked | Locked |
Cloud-based clinical data management platform for healthcare providers
|
Detailed competitors of Truveta
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Truveta
Complete news archive for Truveta
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Truveta
Truveta was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Truveta is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Terry Myerson is the current CEO of Truveta.
Truveta is a funded company, having raised a total of $515M across 4 funding rounds to date.
Truveta was founded in 2020 and is headquartered in Seattle, United States. Operations are focused on the healthcare sector, where a data platform is utilized for learning services. Real-world data from various health systems is aggregated and analyzed to support research and insights. The platform enables secure access to de-identified patient information for collaborative studies. Leadership is provided by CEO Terry Myerson, with emphasis placed on advancing evidence-based healthcare decisions.
Truveta's top competitors include Carta Healthcare, ClearDATA and Verana Health.
Truveta offers Truveta Data, Truveta Language Model, Truveta Studio, and Genomics Solutions.
Truveta has 9 investors. Key investors include Microsoft, Illumina, Regeneron Pharmaceuticals, Providence Health & Services, and Northwell.